TTrialPathMatch Me to Trials
← Back to trials
RecruitingInsomnia ChronicAutism Spectrum Disorder

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Eligible age

6–12 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Children with Autism Spectrum Disorder (ASD) and insomnia, and their parent(s) will undergo 4 sessions of behavioral therapy for sleep problems followed by 4 bimonthly booster sessions. Children and their families will be randomly assigned to one of three conditions: cognitive behavioral therapy (in-person), cognitive behavioral therapy (remote), or behavioral therapy (remote). Arousal will be measured through heart-rate variability. Sleep and secondary outcomes (child daytime behavior, parent sleep) will be collected at baseline (weeks 1-2 before starting the treatment), post-treatment (weeks 6-8 from baseline), 6-month follow-up, and 12-month follow-up.

Sponsor: University of Missouri-Columbia

You may qualify if…

  • 1\) 6-12a yrs
  • 2\) Verbal IQ \>= 70
  • 3\) participation of child's parent or legal guardian living in the same home
  • 4\) parent/guardian ability to read and understand English at the 5th-grade level
  • 5\) child diagnosed with ASD and insomnia
  • ASD:
  • 1\) previous DSM diagnosis of ASD
  • 2\) evaluation using gold-standard diagnostic tools (i.e., Autism Diagnostic Observation Schedule (ADOS) and/or Autism Diagnostic Interview-Revised \[ADI-R\])

You may not qualify if…

  • 1\) parent unable to provide informed consent or child unable to provide assent
  • 2\) unwilling to accept random assignment
  • 3\) participation in another randomized research project
  • 4\) parent unable to complete forms or implement treatment procedures due to cognitive impairment
  • 5\) untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias)
  • 6\) psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin as described in #7 (see Notes below for details)
  • 7\) stimulants, sleep medications (prescribed or OTC), and/or melatonin within the last 1 month (unless stabilized on medication for 3+ months)
  • 8\) participation in non-pharmacological treatment (including CBT) for sleep outside current trial

Where it's recruiting

Missouri

Columbia

Source: ClinicalTrials.gov · NCT04545606 · last updated 2024-03-15